Debjit Chattopadhyay
Stock Analyst at Guggenheim
(2.37)
# 2,405
Out of 4,842 analysts
90
Total ratings
44.44%
Success rate
-1.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Reiterates: Buy | $28 | $15.04 | +86.17% | 6 | May 12, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $55 → $45 | $9.66 | +365.84% | 2 | May 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $81 → $97 | $75.77 | +28.02% | 3 | May 8, 2025 | |
| KRYS Krystal Biotech | Maintains: Buy | $195 → $189 | $123.71 | +52.78% | 4 | May 7, 2025 | |
| BEAM Beam Therapeutics | Maintains: Buy | $78 → $55 | $16.88 | +225.83% | 3 | May 7, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $112 → $98 | $37.23 | +163.23% | 5 | May 7, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $65 → $64 | $32.43 | +97.35% | 5 | May 1, 2025 | |
| MAZE Maze Therapeutics | Reiterates: Buy | $19 | $11.48 | +65.51% | 2 | Apr 2, 2025 | |
| CNTA Centessa Pharmaceuticals | Reiterates: Buy | $28 | $12.95 | +116.22% | 6 | Mar 26, 2025 | |
| RZLT Rezolute | Reiterates: Buy | n/a | $3.95 | - | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $11.76 | - | 4 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.27 | +1,317.32% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $16.14 | +5.33% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $6.11 | +145.50% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $450 → $558 | $445.10 | +25.37% | 7 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $37.23 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $4.97 | +282.29% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.73 | +705.86% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $17.27 | +73.71% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $58.09 | +89.36% | 3 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.14 | +2,443.86% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $0.36 | +2,957.25% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $50 | $34.35 | +45.56% | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $285.81 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $2.44 | +1,047.54% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $6.05 | +230.58% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $29.08 | +322.97% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $11.23 | +380.85% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.20 | +4,900.00% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.83 | - | 3 | Jun 26, 2017 |
uniQure
May 12, 2025
Reiterates: Buy
Price Target: $28
Current: $15.04
Upside: +86.17%
Intellia Therapeutics
May 12, 2025
Maintains: Buy
Price Target: $55 → $45
Current: $9.66
Upside: +365.84%
Soleno Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $81 → $97
Current: $75.77
Upside: +28.02%
Krystal Biotech
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $123.71
Upside: +52.78%
Beam Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $16.88
Upside: +225.83%
Sarepta Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $112 → $98
Current: $37.23
Upside: +163.23%
Ionis Pharmaceuticals
May 1, 2025
Maintains: Buy
Price Target: $65 → $64
Current: $32.43
Upside: +97.35%
Maze Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $19
Current: $11.48
Upside: +65.51%
Centessa Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $28
Current: $12.95
Upside: +116.22%
Rezolute
Feb 10, 2025
Reiterates: Buy
Price Target: n/a
Current: $3.95
Upside: -
Jan 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $11.76
Upside: -
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $1.27
Upside: +1,317.32%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $16.14
Upside: +5.33%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $6.11
Upside: +145.50%
Aug 2, 2024
Maintains: Buy
Price Target: $450 → $558
Current: $445.10
Upside: +25.37%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $37.23
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $4.97
Upside: +282.29%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $2.73
Upside: +705.86%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $17.27
Upside: +73.71%
Sep 13, 2023
Reiterates: Buy
Price Target: $110
Current: $58.09
Upside: +89.36%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.14
Upside: +2,443.86%
Nov 11, 2022
Maintains: Buy
Price Target: $13 → $11
Current: $0.36
Upside: +2,957.25%
Oct 13, 2022
Upgrades: Buy
Price Target: $50
Current: $34.35
Upside: +45.56%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $285.81
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $2.44
Upside: +1,047.54%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $6.05
Upside: +230.58%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $29.08
Upside: +322.97%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $11.23
Upside: +380.85%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.20
Upside: +4,900.00%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $30.83
Upside: -